Helicobacter pylori accumulates photoactive porphyrins and is killed by visible light.
Helicobacter pylori colonizes the mucus layer of the human stomach and duodenum, causes chronic gastritis, gastric ulcer, and is a risk factor for gastric adenocarcinoma. There is a 20% failure rate in antibiotic therapy, which is increasingly due to antibiotic resistance and necessitates the search for alternative antimicrobial methods. We have discovered that H. pylori when cultured in liquid medium, accumulates significant quantities of coproporphyrin and protoporphyrin IX, both in the cells and secreted into the medium. These photoactive porphyrins lead to cell death (up to 5 logs) by photodynamic action upon illumination with low doses of visible light, with blue/violet light being most efficient. The degree of killing increases with the age of the culture and is greater than that found with Propionibacterium acnes (another bacterium known to be photosensitive due to porphyrin accumulation). Both virulent and drug-resistant strains are killed. The data suggest that phototherapy might be used to treat H. pylori infection in the human stomach.
Wellman Center for Photomedicine, Massachusetts General Hospital, 40 Blossom Street, BAR314B, Boston, Massachusetts 02114-2698, USA. hamblin@helix.mgh.harvard.edu
Michael R
MR
Hamblin
Jennifer
J
Viveiros
Changming
C
Yang
Atosa
A
Ahmadi
Robert A
RA
Ganz
M Joshua
MJ
Tolkoff
D000328:Adult; D000368:Aged; D003306:Coproporphyrins / Q000378:metabolism*; D003470:Culture Media; D005260:Female; D016480:Helicobacter pylori / Q000254:growth & development* / Q000378:metabolism / Q000528:radiation effects; D006801:Humans; D008027:Light; D017319:Photosensitizing Agents / Q000378:metabolism*; D011524:Protoporphyrins / Q000378:metabolism*
D003306:Coproporphyrins; D003470:Culture Media; D017319:Photosensitizing Agents; D011524:Protoporphyrins